Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2023-03-31 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于修改公司内部控制相关制度的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding amendments to internal control related systems and governance rules. It lists various company governance and operational rules that have been revised or newly added, and mentions approvals by the board and supervisory committee. The document does not contain financial statements or detailed financial data, nor does it present a full report. It is a regulatory announcement about governance and internal control system changes, not a full governance report or annual report. Given the content and nature, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about internal control and governance system updates.
2023-03-31 Chinese
2022年年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is very short (312 characters) and is titled as a "2022年年度报告披露提示性公告" which translates to "2022 Annual Report Disclosure Reminder Announcement." It states that the 2022 Annual Report and summary have been disclosed on the Shenzhen Stock Exchange website and another information platform, advising investors to review it. This is clearly an announcement about the availability of the annual report rather than the report itself. According to the MENU VS MEAL RULE, such short notices that announce the publication of a report should be classified as Report Publication Announcement (RPA).
2023-03-31 Chinese
2022年度募集资金存放与使用情况专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2022年度募集资金存放与使用情况专项报告" which translates to "2022 Annual Special Report on the Deposit and Use of Raised Funds." It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange related to the management and use of raised funds by listed companies. The content details the amount of funds raised, their deposit, usage, management, and investment projects funded by these raised funds during the year 2022. It includes detailed financial figures and tables about the raised funds usage and balance. This type of document is a specialized report on capital raised and its usage, which aligns with the category of Capital/Financing Update (CAP). It is not a full annual report, audit report, or earnings release, but a focused report on fundraising and capital usage. The document length is sufficient and contains substantive financial data related to capital usage, not just an announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-03-31 Chinese
关于举办2022年度网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding an online performance explanation meeting (业绩说明会) for the 2022 annual report. It mentions that the full 2022 annual report has already been published on the regulatory website. The document invites investors to participate in the meeting to discuss the annual report and company performance. The document length is short (717 characters) and it does not contain the actual annual report or financial data, but rather announces the event related to the annual report. Therefore, this is not the annual report itself (10-K) nor a management discussion (MDA), but an announcement about an investor presentation or earnings explanation meeting. Given the nature of the event (performance explanation meeting) and the invitation to investors, the best fitting category is Investor Presentation (IP). Confidence is high due to clear references to the event and absence of actual financial statements.
2023-03-31 Chinese
独立董事制度
Governance Information Classification · 100% confidence The document is a detailed policy document titled '独立董事制度' (Independent Director System) issued by Tianjin Ruipu Biotechnology Co., Ltd. It outlines the rules, responsibilities, qualifications, nomination, election, and special powers of independent directors, as well as the company's provisions to support them. The content is focused on governance practices and internal rules related to the board of directors, specifically independent directors. There is no financial data, no mention of financial results, no audit opinions, no voting results, no capital changes, no legal proceedings, and no investor presentations. The document is not an announcement or a brief notice but a comprehensive governance framework. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-03-31 Chinese
重大信息内部报告和保密制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled "重大信息内部报告和保密制度" (Major Information Internal Reporting and Confidentiality System) issued by Tianjin Ruipu Biotechnology Co., Ltd. It outlines the procedures, responsibilities, and scope of reporting major information internally within the company, including definitions of major events, reporting obligations, confidentiality duties, and penalties for non-compliance. The document references relevant laws and stock exchange rules but does not contain financial statements, earnings data, or any form of financial results. It is not an announcement of a report, nor a transcript, nor a regulatory filing in the usual sense. It is a governance-related document detailing internal rules and procedures for information disclosure and confidentiality. Therefore, it fits best under Governance Information (CGR). The document length (over 11,000 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2023-03-31 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.